Compare AU
Compare 1GOV vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck 1-5 Year Australian Government Bond ETF (1GOV) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
1GOV | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 2 | 64 |
Median incremental investment | $1,252.75 | $882.72 |
Median investment frequency | Quarterly | Monthly |
Median total investment | $1,297.00 | $1,933.58 |
Average age group | > 35 | 26 - 35 |
Key Summary
1GOV | DRUG | |
|---|---|---|
Strategy | 1GOV.AX was created on 2023-09-26 by VanEck. The fund's investment portfolio concentrates primarily on investment grade fixed income. Each Fund aims to provide an investment return before fees and other costs which tracks the performance of its Reference Index in Australian dollars. The Funds do not necessarily aim to perfectly replicate the Reference Index on a oneto-one basis | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Australia (Commonwealth of) (11.17 %) Australia (Commonwealth of) (8.88 %) Australia (Commonwealth of) (8.36 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Other (77.05 %) Communication Services (33.53 %) Health Care (22.79 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.22 % | 0.57 % |
Key Summary
1GOV | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | S&P/ASX Government Bond Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.22 % | 0.57 % |
Price | $51.88 | $7.48 |
Size | $20.487 million | $168.727 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.84 % | 1.89 % |
Market | ASX | ASX |
First listed date | 27/09/2023 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
1GOV | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 2 | 64 |
Median incremental investment | $1,252.75 | $882.72 |
Median investment frequency | Quarterly | Monthly |
Median total investment | $1,297.00 | $1,933.58 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
1GOV | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
1GOV | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |